A patient with a confirmed diagnosis of iron deficiency anemia is not responding to oral iron supplementation. Which of the following actions should the nurse prioritize to address the underlying cause of the anemia?

B) Recommend an evaluation for gastrointestinal malabsorption conditions.

A) Increase the dose of oral iron supplementation.

B) Recommend an evaluation for gastrointestinal malabsorption conditions.

C) Advise the patient to consume more dietary iron-rich foods.

D) Suggest monitoring thyroid levels more frequently.

A patient with confirmed iron deficiency anemia is not responding to oral iron supplementation. Which of the following nursing interventions is most appropriate to address the underlying issue of impaired iron absorption?

A) Suggest switching to a ferrous sulfate preparation that includes vitamin C to enhance absorption.

B) Increase the frequency of oral iron supplementation to three times daily.

C) Recommend a high-calcium diet to support overall bone health.

D) Encourage the patient to take iron supplements with meals to reduce gastrointestinal discomfort.

A patient with microcytic anemia has shown no improvement with oral iron supplementation and reports persistent fatigue and new-onset dyspnea on exertion. Her hemoglobin level is 8.8 g/dL, and serum ferritin is critically low. Which nursing intervention is most appropriate to address the current situation?

B) Initiate intravenous iron therapy as prescribed and monitor for adverse reactions

A) Educate the patient on increasing dietary iron intake and reassess in four weeks

B) Initiate intravenous iron therapy as prescribed and monitor for adverse reactions

C) Suggest the patient increase physical activity to improve cardiovascular fitness

D) Encourage the patient to use supplemental oxygen during exertion to alleviate symptoms

A patient with persistent fatigue and shortness of breath is found to have a hemoglobin level of 8.8 g/dL and a serum ferritin of 7 ng/mL. Despite oral iron therapy, her condition has not improved. What is the most appropriate nursing intervention to prioritize at this point in her care?

B) Recommend the initiation of intravenous iron therapy.

A) Educate the patient on the importance of dietary iron intake.

B) Recommend the initiation of intravenous iron therapy.

C) Advise the patient to increase oral iron dosage.

D) Encourage the patient to rest and monitor symptoms at home.

A patient undergoing intravenous iron therapy for anemia reports persistent fatigue and shortness of breath, despite a modest increase in hemoglobin and ferritin levels. Which of the following actions should the nurse prioritize to further investigate the underlying cause of the patient's anemia?

C) Collaborate with the healthcare provider to evaluate for potential gastrointestinal bleeding

A) Increase the frequency of intravenous iron infusions

B) Educate the patient on dietary sources of vitamin B12 and folate

C) Collaborate with the healthcare provider to evaluate for potential gastrointestinal bleeding

D) Suggest the use of supplemental oxygen during activities

A patient with a history of anemia presents with positive fecal occult blood test results, gastric erosions, a small duodenal ulcer, and borderline low vitamin B12 levels. Which of the following interventions should the nurse prioritize to effectively address the patient's anemia?

C) Provide vitamin B12 supplementation to address potential deficiency.

A) Administer oral iron supplements to correct the anemia.

B) Initiate a high-fiber diet to manage gastrointestinal symptoms.

C) Provide vitamin B12 supplementation to address potential deficiency.

D) Encourage increased fluid intake to promote renal excretion of toxins.

A patient with anemia is found to have gastric erosions, a small duodenal ulcer, and borderline low vitamin B12. Which nursing intervention is most appropriate to address the multifactorial causes of the patient's anemia?

B) Administer vitamin B12 injections as prescribed and monitor for improvement in symptoms.

A) Encourage the patient to increase intake of iron-rich foods.

B) Administer vitamin B12 injections as prescribed and monitor for improvement in symptoms.

C) Educate the patient on the importance of taking a proton pump inhibitor to reduce gastric acidity.

D) Recommend a high-fiber diet to promote gastrointestinal health.

A patient with anemia secondary to chronic blood loss and borderline vitamin B12 levels is receiving treatment with vitamin B12 supplementation and intravenous iron therapy. Despite some improvement in hemoglobin levels, she continues to experience palpitations and shortness of breath upon exertion. Which intervention should the nurse prioritize to address the persistent symptoms?

C) Collaborate with the healthcare team to reassess the current treatment plan

A) Increase the frequency of hemoglobin monitoring to weekly

B) Educate the patient about dietary sources of vitamin B12

C) Collaborate with the healthcare team to reassess the current treatment plan

D) Advise the patient to reduce physical activity until symptoms improve

A patient with chronic anemia is showing a modest improvement in hemoglobin levels after three weeks of vitamin B12 supplementation and intravenous iron therapy. However, she still experiences occasional palpitations and shortness of breath on exertion. Which of the following nursing interventions would be most appropriate at this stage to address her symptoms?

C) Educate the patient on energy conservation techniques and signs of overexertion.

A) Increase the frequency of iron therapy sessions.

B) Encourage the patient to increase physical activity to improve cardiovascular fitness.

C) Educate the patient on energy conservation techniques and signs of overexertion.

D) Suggest a high-protein diet to support increased hemoglobin production.

low blood iron concentration - Nursing Case Study

Pathophysiology

• Primary mechanism: Inadequate dietary intake or absorption of iron, often due to gastrointestinal disorders or insufficient consumption of iron-rich foods, leads to decreased availability for hemoglobin synthesis, causing low blood iron levels.

• Secondary mechanism: Chronic blood loss, such as from heavy menstruation or gastrointestinal bleeding, results in the depletion of iron stores as the body compensates for the ongoing loss, further lowering blood iron concentration.

• Key complication: Reduced hemoglobin production due to low iron impairs oxygen transport in the body, potentially leading to symptoms of anemia, such as fatigue and pallor, which are clinically significant for patient care.

Patient Profile

Demographics:

32-year-old female, office manager

History:

• Key past medical history: Iron deficiency anemia diagnosed 2 years ago, mild hypothyroidism

• Current medications: Levothyroxine 50 mcg daily, ferrous sulfate 325 mg once daily

• Allergies: Penicillin (rash)

Current Presentation:

• Chief complaint: Persistent fatigue and shortness of breath

• Key symptoms: Dizziness, pale skin, brittle nails, headache, occasional heart palpitations

• Vital signs: Blood pressure 110/70 mmHg, heart rate 96 bpm, respiratory rate 20 breaths per minute, temperature 98.6°F, oxygen saturation 95% on room air

Section 1

New Diagnostic Results:

Upon further investigation, the patient's laboratory work reveals a hemoglobin level of 9.4 g/dL, which is lower than the normal range, confirming a state of anemia. Additionally, her serum ferritin level is 8 ng/mL, indicating severely depleted iron stores. The mean corpuscular volume (MCV) is 72 fL, suggesting microcytic anemia, commonly associated with iron deficiency. The patient's total iron binding capacity (TIBC) is elevated at 450 mcg/dL, further supporting the diagnosis of iron deficiency anemia. Her thyroid function tests remain stable, with a TSH level of 2.0 mIU/L, indicating that her hypothyroidism is well-controlled with the current dose of levothyroxine.

These results suggest that despite oral iron supplementation, the patient's iron deficiency is not adequately addressed. This finding necessitates exploring potential causes for impaired absorption or additional sources of iron loss. Given her history and clinical presentation, further evaluation for gastrointestinal pathology, such as celiac disease or inflammatory bowel disease, may be warranted. Additionally, the possibility of heavy menstrual bleeding contributing to chronic blood loss should be considered, and a referral to a gynecologist for further assessment may be appropriate.

The healthcare team must now strategize on optimizing iron repletion while addressing potential underlying causes. Options may include increasing the dose or frequency of oral iron, considering intravenous iron therapy, or implementing dietary modifications to enhance iron absorption. The team must also remain vigilant for signs of worsening anemia or new complications, such as cardiac strain due to increased heart rate, as these could impact the patient's overall health and quality of life.

Section 2

Change in Patient Status:

After implementing dietary adjustments and optimizing oral iron supplementation, the patient returns for a follow-up appointment two weeks later. During this visit, she reports persistent fatigue, which has begun to interfere with her daily activities and work responsibilities. She also mentions experiencing shortness of breath during mild exertion, such as climbing a flight of stairs, which is a new development for her. On physical examination, she appears pale, and her heart rate is elevated at 102 beats per minute, indicating a compensatory mechanism for the decreased oxygen-carrying capacity of her blood. Her blood pressure is 110/70 mmHg, and she has no signs of peripheral edema, but her breathing is slightly labored.

Given these symptoms and the lack of significant improvement with oral iron therapy, the healthcare team decides to repeat the laboratory tests to assess any changes in her hematological status. The results reveal a hemoglobin level of 8.8 g/dL, a slight decline from the previous value, suggesting ongoing blood loss or poor absorption of oral iron. The serum ferritin remains critically low at 7 ng/mL, and the MCV continues to indicate microcytic anemia at 70 fL. These findings confirm that the current management strategy is insufficient and raise concerns about the potential for developing more severe anemia-related complications, such as heart failure or significant functional impairment.

The team discusses the need for more aggressive intervention, considering intravenous iron therapy as a viable option to rapidly replenish iron stores and improve the patient's symptoms. Additionally, the decision is made to expedite the gastrointestinal evaluation to rule out malabsorption syndromes or other sources of chronic blood loss. A referral to a cardiologist may also be prudent, given the patient's tachycardia and potential cardiac strain. These steps are essential to prevent further deterioration of her condition and to address the underlying causes, ensuring a comprehensive approach to her care.

Section 3

Change in Patient Status:

Following the decision to initiate intravenous iron therapy, the patient is admitted to the infusion center for her first treatment. During the infusion, the patient tolerates the iron administration well, with no immediate adverse reactions, and she is discharged with instructions to monitor for any delayed side effects. Over the next week, the patient reports a slight improvement in her energy levels, though she still experiences fatigue and shortness of breath with moderate exertion. On her next follow-up visit, her vital signs show a heart rate of 98 beats per minute, blood pressure of 112/68 mmHg, and a respiratory rate of 20 breaths per minute, suggesting a mild improvement in her cardiovascular strain. However, she remains pale, and her physical activity is still limited.

The healthcare team receives new laboratory results following the intravenous iron therapy. Her hemoglobin level has increased modestly to 9.2 g/dL, indicating a positive response to the treatment, though still below the normal range. Serum ferritin has improved to 15 ng/mL, reflecting some replenishment of iron stores, but it remains low enough to warrant continued monitoring. Despite these improvements, the patient's persistent symptoms and incomplete recovery suggest that additional factors may be contributing to her anemia. A fecal occult blood test is ordered to investigate potential gastrointestinal bleeding, and an upper endoscopy is scheduled to further evaluate for malabsorption issues, such as celiac disease or inflammatory bowel conditions.

As the patient continues to receive scheduled intravenous iron infusions, the healthcare team remains vigilant for any new symptoms or complications. The slight uptick in her hemoglobin and ferritin levels is encouraging, yet the persistence of her fatigue and shortness of breath implies that the underlying cause of her anemia needs further elucidation. The team considers the potential for coexisting conditions such as vitamin B12 or folate deficiency and plans to conduct additional tests to explore these possibilities. The integration of these findings into the patient's care plan will be crucial in refining her treatment strategy and improving her overall quality of life.

Section 4

New Diagnostic Results:

During the follow-up visit, the results from the fecal occult blood test return positive, indicating the presence of blood in the gastrointestinal tract. This finding raises suspicions of an underlying bleeding source, necessitating further investigation. The scheduled upper endoscopy reveals evidence of gastric erosions and a small duodenal ulcer, suggesting the possibility of chronic blood loss contributing to the patient's anemia. Additionally, histological examination of the duodenal biopsy does not show typical signs of celiac disease, but mild inflammation is noted, raising the possibility of non-specific enteritis.

In parallel, the vitamin B12 and folate levels are assessed to rule out other contributing factors for anemia. The results show that while the folate level is within the normal range, the vitamin B12 level is borderline low at 210 pg/mL. This finding suggests that there may be a component of vitamin B12 deficiency, potentially exacerbating the patient's anemia and contributing to her persistent symptoms. Given these results, the healthcare team decides to initiate vitamin B12 supplementation, along with the continued intravenous iron therapy, to address the potential multifactorial nature of the anemia.

The integration of these new findings prompts a reevaluation of the patient's treatment plan. The combination of gastric erosion and vitamin B12 deficiency requires a multidisciplinary approach, potentially involving gastroenterology for management of the gastrointestinal bleeding and nutrition services for dietary guidance. The healthcare team remains alert for any changes in the patient’s condition, understanding that a comprehensive, targeted approach will be essential for achieving a more complete resolution of her anemia and improving her overall quality of life. As these interventions are implemented, the team will closely monitor her response, looking for improvements in her hemoglobin levels, energy levels, and overall symptomatology.

Section 5

Response to Interventions:

As the patient begins the newly adjusted treatment plan, the healthcare team closely monitors her progress through regular follow-ups. Initial assessments indicate that after three weeks of vitamin B12 supplementation and continued intravenous iron therapy, there is a modest increase in the patient's hemoglobin levels, rising from 9.0 g/dL to 10.2 g/dL. This improvement suggests a positive response to the interventions, although the increase is slower than anticipated. The patient reports a slight improvement in her fatigue and notes a decrease in lightheadedness. However, she continues to experience occasional palpitations and shortness of breath, especially upon exertion.

Vital signs taken during a subsequent visit show a blood pressure of 110/70 mmHg, heart rate of 98 beats per minute, and respiratory rate of 20 breaths per minute. Her weight remains stable, and no new gastrointestinal symptoms are reported. Despite the improvements, the persistence of certain symptoms prompts further clinical reasoning. The healthcare team hypothesizes that while the anemia is being addressed, the patient may still be experiencing residual effects from the chronic blood loss and borderline vitamin B12 levels.

To gain more insight into her ongoing symptoms, the team decides to perform another round of laboratory tests, including a repeat complete blood count, reticulocyte count, and serum ferritin. Additionally, they plan to reassess her vitamin B12 levels to ensure adequate absorption and utilization. Collaboration with the gastroenterologist continues to ensure that the gastric erosions and duodenal ulcer are healing, as unresolved gastrointestinal issues could further complicate her recovery. The healthcare team remains committed to a holistic approach, considering the complex interplay of factors contributing to the patient’s anemia and overall health, and prepares to adjust the treatment plan as needed based on the latest findings.